PL2309983T3 - Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę - Google Patents

Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę

Info

Publication number
PL2309983T3
PL2309983T3 PL09775591T PL09775591T PL2309983T3 PL 2309983 T3 PL2309983 T3 PL 2309983T3 PL 09775591 T PL09775591 T PL 09775591T PL 09775591 T PL09775591 T PL 09775591T PL 2309983 T3 PL2309983 T3 PL 2309983T3
Authority
PL
Poland
Prior art keywords
tetrahydrobiopterin
pharmaceutical form
pharmaceutical
Prior art date
Application number
PL09775591T
Other languages
English (en)
Inventor
Rudolf Widmann
Andreas Bernkop-Schnuerch
Original Assignee
Orpha Swiss Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orpha Swiss Gmbh filed Critical Orpha Swiss Gmbh
Publication of PL2309983T3 publication Critical patent/PL2309983T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL09775591T 2008-08-12 2009-08-07 Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę PL2309983T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT12542008 2008-08-12
PCT/AT2009/000306 WO2010017570A2 (de) 2008-08-12 2009-08-07 Pharmazeutische darreichungsform enthaltend tetrahydrobiopterin
EP09775591.2A EP2309983B1 (de) 2008-08-12 2009-08-07 Pharmazeutische darreichungsform enthaltend tetrahydrobiopterin

Publications (1)

Publication Number Publication Date
PL2309983T3 true PL2309983T3 (pl) 2019-09-30

Family

ID=41111155

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09775591T PL2309983T3 (pl) 2008-08-12 2009-08-07 Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę

Country Status (8)

Country Link
US (1) US20110144117A1 (pl)
EP (1) EP2309983B1 (pl)
JP (1) JP2011530540A (pl)
ES (1) ES2736730T3 (pl)
PL (1) PL2309983T3 (pl)
RU (1) RU2011109210A (pl)
TR (1) TR201910287T4 (pl)
WO (1) WO2010017570A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014202925B2 (en) * 2013-01-10 2015-07-09 Nutritional Therapeutics, Inc. Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders
PL2926805T3 (pl) * 2014-03-31 2016-12-30 Stałe kompozycje farmaceutyczne zawierające pochodne biopteryny oraz zastosowania takich kompozycji
MA46972A (fr) 2016-11-29 2019-10-09 Censa Pharmaceuticals Inc Forme polymorphe de sépiaptérine
MA46973A (fr) 2016-11-29 2019-10-09 Censa Pharmaceuticals Inc Polymorphes de sépiaptérine et leurs sels
CA3073957A1 (en) * 2017-09-01 2019-03-07 Censa Pharmaceuticals Inc. Pharmaceutical compositions comprising sepiapterin and uses thereof
SMT202400430T1 (it) 2018-05-30 2024-11-15 Ptc Therapeutics Mp Inc Somministrazione di sepiapterina, senza alcun alimento, per uso in un metodo per incrementare l’esposizione plasmatica di sepiapterina
WO2019232126A1 (en) 2018-05-30 2019-12-05 Censa Pharmaceuticals Inc. Compositions and methods for increasing tetrahydrobiopterin plasma exposure
JP7553906B2 (ja) * 2018-11-01 2024-09-19 宏 一瀬 Ｓｐｒをコードするポリヌクレオチドを含む組換えベクター、及びそれを含む組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61277618A (ja) * 1985-06-04 1986-12-08 Suntory Ltd 自閉症治療剤
JP2588191B2 (ja) * 1987-04-24 1997-03-05 サントリー株式会社 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
DE10260263A1 (de) * 2002-12-20 2004-07-15 Biocrates Life Sciences Gmbh Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen
JP4964587B2 (ja) * 2004-05-11 2012-07-04 第一三共株式会社 Ｂｈ４反応性高フェニルアラニン血症治療剤
EP2436379A1 (en) * 2004-11-17 2012-04-04 BioMarin Pharmaceutical Inc. Stable tablet formulation
US20060188492A1 (en) * 2005-01-13 2006-08-24 Chronorx Llc, An Alaska Limited Liability Company Topical management of ocular and periocular conditions
KR20080005601A (ko) * 2005-05-11 2008-01-14 니코메드 게엠베하 Ｐｄｅ４ 억제제 로플루밀라스트와 테트라히드로비오프테린유도체의 조합
PL2139485T3 (pl) * 2007-04-11 2013-03-29 Biomarin Pharm Inc Metoda podawania tetrahydrobiopteryny, powiązane kompozycje i sposoby pomiaru

Also Published As

Publication number Publication date
TR201910287T4 (tr) 2019-07-22
US20110144117A1 (en) 2011-06-16
WO2010017570A2 (de) 2010-02-18
WO2010017570A3 (de) 2010-08-05
ES2736730T3 (es) 2020-01-07
JP2011530540A (ja) 2011-12-22
EP2309983A2 (de) 2011-04-20
RU2011109210A (ru) 2012-09-20
EP2309983B1 (de) 2019-04-24

Similar Documents

Publication Publication Date Title
IL237391A0 (en) Pharmaceutical combination
IL228817A0 (en) Pharmaceutical compounds
IL207378A0 (en) Pharmaceutical solid state forms
SI2364137T1 (sl) Farmacevtska suspenzija
ZA201104348B (en) Pharmaceutical preparation
GB0810615D0 (en) Novel pharmaceutical
GB0812969D0 (en) Pharmaceutical compounds
HU0800591D0 (en) Stable pharmaceutical combination
GB0816370D0 (en) Pharmaceutical compounds
GB0806527D0 (en) Pharmaceutical compounds
IL208387A0 (en) Pharmaceutical composition
PL2309983T3 (pl) Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę
GB0815972D0 (en) Pharmaceutical preparation
IL208953A0 (en) Pharmaceutical combination
GB0810857D0 (en) Pharmaceutical compounds
ZA201006224B (en) Pharmaceutical composition
GB2464200B (en) Pharmaceutical composition
GB0810617D0 (en) Novel pharmaceutical
GB0817969D0 (en) Pharmaceutical composition
HU0800414D0 (en) Pharmaceutical combination
GB0804486D0 (en) Novel pharmaceutical composituons
GB0810217D0 (en) Pharmaceutical formulations
GB0813031D0 (en) Pharmaceutical formulations
GB0802576D0 (en) Dosage form
GB0817974D0 (en) Pharmaceutical composition